TRIAL IN PROGRESS: A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF AXATILIMAB VERSUS BEST AVAILABLE THERAPY IN PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER ≥2 PRIOR LINES OF SYSTEMIC THERAPY
EHA Library, Mi Kwon,
4159502
A NOVEL CANCER VACCINE BASED ON HYALURONIC ACID NANOGEL (HANG) IMPROVES THE NUMBER AND FUNCTIONS OF INFUSED TCR-T CELLS, ESPECIALLY INDUCES „ANTIGEN-SPREADING”, RESULTING IN LONG-TERM CURE OF IMMUNOTHERAPY-RESISTANT SOLID TUMORS
EHA Library, Fumiyasu Momose,
4159556
CD19/CD22 BISPECIFIC CAR-T CELL THERAPY FOR RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA: A PROSPECTIVE, SINGLE-ARM, SINGLE-CENTER, PHASE 2 CLINICAL TRIAL
EHA Library, Liang Wang,
4159569
Integrated Editing and Manufacturing Process Design for BEAM-101, an Autologous CD34+ HSPC Therapy for Sickle Cell Disease, Results in Robust Process Yield and Increased HbF Induction
EHA Library, Paul Kopesky,
4159577